Moomoo AI 已提取核心信息
On February 29, 2024, Intelligent Bio Solutions Inc., a Delaware-incorporated company listed on The Nasdaq Stock Market under the symbol INBS, reported entering into two separate agreements to enhance its advisory and investor relations services. The first agreement, with C2C Advisors Inc., involves a 6-month term where C2C will provide advisory services for a monthly fee of $25,000 and a one-time grant of 37,500 restricted shares of common stock. The second agreement, with ClearThink Capital LLC, includes an initial grant of 5,260 restricted shares and a monthly fee of $5,000 plus $4,000 worth of restricted common stock, calculated quarterly. Both agreements are effective as of February 29, 2024, with the ClearThink Agreement allowing for termination by either party after three months. The shares from both agreements will be issued under an exemption from registration according to Section 4(a)(2) of the Securities Act of 1933.
On February 29, 2024, Intelligent Bio Solutions Inc., a Delaware-incorporated company listed on The Nasdaq Stock Market under the symbol INBS, reported entering into two separate agreements to enhance its advisory and investor relations services. The first agreement, with C2C Advisors Inc., involves a 6-month term where C2C will provide advisory services for a monthly fee of $25,000 and a one-time grant of 37,500 restricted shares of common stock. The second agreement, with ClearThink Capital LLC, includes an initial grant of 5,260 restricted shares and a monthly fee of $5,000 plus $4,000 worth of restricted common stock, calculated quarterly. Both agreements are effective as of February 29, 2024, with the ClearThink Agreement allowing for termination by either party after three months. The shares from both agreements will be issued under an exemption from registration according to Section 4(a)(2) of the Securities Act of 1933.
2024年2月29日，在纳斯达克股票市场上市的特拉华州注册公司Intelligent Bio Solutions Inc. 报告说，已签订两份单独的协议，以加强其咨询和投资者关系服务。与C2C Advisors Inc.签订的第一份协议涉及6个月的期限，其中C2C将提供咨询服务，月费为25,000美元，并一次性授予37,500股限制性普通股。与ClearThink Capital LLC签订的第二份协议包括初始授予5,260股限制性股票和5,000美元的月费外加价值4,000美元的限制性普通股，按季度计算。这两项协议均自2024年2月29日起生效，ClearThink协议允许任何一方在三个月后终止。根据1933年《证券法》第4（a）（2）条，这两份协议中的股票将在注册豁免的情况下发行。
2024年2月29日，在纳斯达克股票市场上市的特拉华州注册公司Intelligent Bio Solutions Inc. 报告说，已签订两份单独的协议，以加强其咨询和投资者关系服务。与C2C Advisors Inc.签订的第一份协议涉及6个月的期限，其中C2C将提供咨询服务，月费为25,000美元，并一次性授予37,500股限制性普通股。与ClearThink Capital LLC签订的第二份协议包括初始授予5,260股限制性股票和5,000美元的月费外加价值4,000美元的限制性普通股，按季度计算。这两项协议均自2024年2月29日起生效，ClearThink协议允许任何一方在三个月后终止。根据1933年《证券法》第4（a）（2）条，这两份协议中的股票将在注册豁免的情况下发行。
有用
没用